NCT00348153View on ClinicalTrials.gov

Adalimumab in Uveitis Refractory to Conventional Therapy (ADUR Trial)

PHASE2/PHASE3UnknownINTERVENTIONAL

Enrollment

40

Participants

Timeline

Start Date

August 31, 2006

Primary Completion Date

September 30, 2012

Study Completion Date

March 31, 2013

Conditions

Uveitis

Interventions

DRUG

Adalimumab

Trial Locations (1)

69120

Interdisciplinary Uveitis Center, University of Heidelberg, Heidelberg

Sponsors

Collaborators (1)

All Listed Sponsors

collaborator

Abbott

INDUSTRY

lead

Heidelberg University

OTHER